http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019216755-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d3d6ffd8187147dbd854f5e70a99a88 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-32 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-32 |
filingDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee705e5666e1757539cda1ec5137bae7 |
publicationDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019216755-A |
titleOfInvention | Hemostatic material |
abstract | A hemostatic material that can be easily and safely manufactured, has no risk of virus infection, and can coagulate blood without Ca ions. [Solution] (1) A first agent containing a gelatin derivative having a hydrophobic group bonded via an imino group, wherein the gelatin derivative has (a) a weight average molecular weight of 10,000 to 50,000, (B) the hydrophobic group is an alkyl group having 6 to 18 carbon atoms, and (c) the imino group / amino group (molar ratio) in the gelatin derivative is 1/99 to 30/70. A hemostatic material comprising a first agent and (2) a second agent comprising a crosslinking agent for the gelatin derivative. [Selection diagram] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021261080-A1 |
priorityDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.